I"#e<h1 id="putative-loss-of-function">Putative loss-of-function</h1>

<ul id="markdown-toc">
  <li><a href="#putative-loss-of-function" id="markdown-toc-putative-loss-of-function">Putative loss-of-function</a></li>
  <li><a href="#identification-of-plof-variants" id="markdown-toc-identification-of-plof-variants">Identification of pLoF variants</a>    <ul>
      <li><a href="#methods" id="markdown-toc-methods">Methods</a></li>
      <li><a href="#results" id="markdown-toc-results">Results</a></li>
      <li><a href="#references" id="markdown-toc-references">References</a></li>
    </ul>
  </li>
</ul>

<h1 id="identification-of-plof-variants">Identification of pLoF variants</h1>
<p><a href="https://www.nature.com/articles/s41586-021-03205-y">As reported in “Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program”</a>.\</p>
<h2 id="methods">Methods</h2>
<p>pLOF variants were identified using Loss Of Function Transcript Effect Estimator (LOFTEE) v.0.3-beta85 
and Variant Effect Predictor (VEP) v.9486.
The genomic coordinates of coding elements were based on GENCODE v.2915. Only stop-gained, frameshift and splice-site-disturbing variants annotated as high-confidence pLOF variants were used in the analysis. The pLOF variants with allele frequency &gt; 0.5% or within regions masked due to poor accessibility were excluded from analysis (see Supplementary Information 1.5 for details).
 <a class="citation" href="#abolhassani2014hypomorphic">(Abolhassani et al., 2014)</a></p>

<p>We evaluated the enrichment and depletion of pLOF variants (allele frequency &lt; 0.5%) in gene sets (that is, terms) from Gene Ontology (GO)87,88. For each gene annotated with a particular GO term, we computed the number of pLOF variants per protein-coding base pair, L, and proportion of singletons, S. We then tested for lower or higher mean L and S in a GO term using bootstrapping (1,000,000 samples) with adjustment for the gene length of the protein-coding sequence (CDS): (1) sort all genes by their CDS length in ascending order and divide them into equal-size bins (1,000 genes each); (2) count how many genes from a GO term are in each bin; (3) from each bin, sample with replacement the same number of genes and compute the average L and S; (4) count how many times sampled L and S were lower or higher than observed values. The P values were computed as the proportion of bootstrap samples that exceeded the observed values. The fold change of average L and S was computed as a ratio of observed values to the average of sampled values. We tested all 12,563 GO terms that included more than one gene. The P-value significance threshold was thus ~2 × 10−6. The enrichment and depletion of pLOF variants in public gene databases was tested in a similar way.</p>

<h2 id="results">Results</h2>
<p>A notable class of variants is the 228,966 putative loss-of-function (pLOF) variants that we observed in 18,493 (95.0%) GENCODE15 genes (Extended Data Table 5 and Supplementary Fig. 12). This class includes the highest proportion of singletons among all of the variant classes that we examined. An average individual carried 2.5 unique pLOF variants. We identified more pLOF variants per individual than in previous surveys based on exome sequencing—an increase that was mainly driven by the identification of additional frameshift variants (Supplementary Table 6) and by a more uniform and complete coverage of protein-coding regions (Supplementary Figs. 13, 14).</p>

<p>We searched for gene sets with fewer rare pLOF variants than expected based on gene size. The gene sets with strong functional constraint included genes that encode DNA- and RNA-binding proteins, spliceosomal complexes, translation initiation machinery and RNA splicing and processing proteins (Supplementary Table 7). Genes associated with human disease in COSMIC17 (31% depletion), the GWAS catalogue18 (around 8% depletion), OMIM19 (4% depletion) and ClinVar20 (4% depletion) all contained fewer rare pLOF variants than expected (each comparison P &lt; 10−4).</p>

<h2 id="references">References</h2>

<ol class="bibliography"><li><span id="abolhassani2014hypomorphic">Abolhassani, H., Wang, N., Aghamohammadi, A., Rezaei, N., Lee, Y. N., Frugoni, F., Notarangelo, L. D., Pan-Hammarström, Q., &amp; Hammarström, L. (2014). A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. <i>Journal of Allergy and Clinical Immunology</i>, <i>134</i>(6), 1375–1380.</span></li>
<li><span id="agrawal1998transposition">Agrawal, A., Eastman, Q. M., &amp; Schatz, D. G. (1998). Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. <i>Nature</i>, <i>394</i>(6695), 744.</span></li>
<li><span id="altman1995statistics">Altman, D. G., &amp; Bland, J. M. (1995). Statistics notes: Absence of evidence is not evidence of absence. <i>Bmj</i>, <i>311</i>(7003), 485.</span></li>
<li><span id="asai2011analysis">Asai, E., Wada, T., Sakakibara, Y., Toga, A., Toma, T., Shimizu, T., Nampoothiri, S., Imai, K., Nonoyama, S., Morio, T., &amp; others. (2011). Analysis of mutations and recombination activity in RAG-deficient patients. <i>Clinical Immunology</i>, <i>138</i>(2), 172–177.</span></li>
<li><span id="avila2010highly">Avila, E. M., Uzel, G., Hsu, A., Milner, J. D., Turner, M. L., Pittaluga, S., Freeman, A. F., &amp; Holland, S. M. (2010). Highly variable clinical phenotypes of hypomorphic RAG1 mutations. <i>Pediatrics</i>, <i>126</i>(5), e1248–e1252.</span></li>
<li><span id="bartha2017human">Bartha, I., di Iulio, J., Venter, J. C., &amp; Telenti, A. (2017). Human gene essentiality. <i>Nature Reviews Genetics</i>, nrg–2017.</span></li>
<li><span id="buchbinder2015identification">Buchbinder, D., Baker, R., Lee, Y. N., Ravell, J., Zhang, Y., McElwee, J., Nugent, D., Coonrod, E. M., Durtschi, J. D., Augustine, N. H., &amp; others. (2015). Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders. <i>Journal of Clinical Immunology</i>, <i>35</i>(2), 119–124.</span></li>
<li><span id="casanova2014guidelines">Casanova, J.-L., Conley, M. E., Seligman, S. J., Abel, L., &amp; Notarangelo, L. D. (2014). Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. <i>Journal of Experimental Medicine</i>, jem–20140520.</span></li>
<li><span id="chan2014excess">Chan, Y., Lim, E. T., Sandholm, N., Wang, S. R., McKnight, A. J., Ripke, S., Daly, M. J., Neale, B. M., Salem, R. M., Hirschhorn, J. N., &amp; others. (2014). An excess of risk-increasing low-frequency variants can be a signal of polygenic inheritance in complex diseases. <i>The American Journal of Human Genetics</i>, <i>94</i>(3), 437–452.</span></li>
<li><span id="chou2012novel">Chou, J., Hanna-Wakim, R., Tirosh, I., Kane, J., Fraulino, D., Lee, Y. N., Ghanem, S., Mahfouz, I., Mégarbané, A., Lefranc, G., &amp; others. (2012). A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome. <i>Journal of Allergy and Clinical Immunology</i>, <i>130</i>(6), 1414–1416.</span></li>
<li><span id="clark2018scnmt">Clark, S. J., Argelaguet, R., Kapourani, C.-A., Stubbs, T. M., Lee, H. J., Alda-Catalinas, C., Krueger, F., Sanguinetti, G., Kelsey, G., Marioni, J. C., &amp; others. (2018). scNMT-seq enables joint profiling of chromatin accessibility DNA methylation and transcription in single cells. <i>Nature Communications</i>, <i>9</i>(1), 781.</span></li>
<li><span id="conley2014discovery">Conley, M. E., &amp; Casanova, J.-L. (2014). Discovery of single-gene inborn errors of immunity by next generation sequencing. <i>Current Opinion in Immunology</i>, <i>30</i>, 17–23.</span></li>
<li><span id="corneo2001identical">Corneo, B., Moshous, D., Güngör, T., Wulffraat, N., Philippet, P., Le Deist, F., Fischer, A., &amp; de Villartay, J.-P. (2001). Identical mutations in RAG1 or RAG2 genes leading to defective V (D) J recombinase activity can cause either TB–severe combined immune deficiency or Omenn syndrome. <i>Blood</i>, <i>97</i>(9), 2772–2776.</span></li>
<li><span id="crestani2014rag1">Crestani, E., Choo, S., Frugoni, F., Lee, Y. N., Richards, S., Smart, J., &amp; Notarangelo, L. D. (2014). RAG1 reversion mosaicism in a patient with omenn syndrome. <i>Journal of Clinical Immunology</i>, <i>34</i>(5), 551–554.</span></li>
<li><span id="dalal2005evolution">Dalal, I., Tabori, U., Bielorai, B., Golan, H., Rosenthal, E., Amariglio, N., Rechavi, G., &amp; Toren, A. (2005). Evolution of a TB-SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection. <i>Clinical Immunology</i>, <i>115</i>(1), 70–73.</span></li>
<li><span id="de1991restricted">de Saint-Basile, G., Le Deist, F., De Villartay, J. P., Cerf-Bensussan, N., Journet, O., Brousse, N., Griscelli, C., &amp; Fischer, A. (1991). Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s syndrome). <i>The Journal of Clinical Investigation</i>, <i>87</i>(4), 1352–1359.</span></li>
<li><span id="de2005novel">De Villartay, J.-P., Lim, A., Al-Mousa, H., Dupont, S., Déchanet-Merville, J., Coumau-Gatbois, E., Gougeon, M.-L., Lemainque, A., Eidenschenk, C., Jouanguy, E., &amp; others. (2005). A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. <i>The Journal of Clinical Investigation</i>, <i>115</i>(11), 3291–3299.</span></li>
<li><span id="de2010hypomorphic">De Ravin, S. S., Cowen, E. W., Zarember, K. A., Whiting-Theobald, N. L., Kuhns, D. B., Sandler, N. G., Douek, D. C., Pittaluga, S., Poliani, P. L., Lee, Y. N., &amp; others. (2010). Hypomorphic Rag mutations can cause destructive midline granulomatous disease. <i>Blood</i>, <i>116</i>(8), 1263–1271.</span></li>
<li><span id="felgentreff2011clinical">Felgentreff, K., Perez-Becker, R., Speckmann, C., Schwarz, K., Kalwak, K., Markelj, G., Avcin, T., Qasim, W., Davies, E. G., Niehues, T., &amp; others. (2011). Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. <i>Clinical Immunology</i>, <i>141</i>(1), 73–82.</span></li>
<li><span id="fugmann2006ancient">Fugmann, S. D., Messier, C., Novack, L. A., Cameron, R. A., &amp; Rast, J. P. (2006). An ancient evolutionary origin of the Rag1/2 gene locus. <i>Proceedings of the National Academy of Sciences of the United States of America</i>, <i>103</i>(10), 3728–3733.</span></li>
<li><span id="gomez2000mutations">Gomez, C. A., Ptaszek, L. M., Villa, A., Bozzi, F., Sobacchi, C., Brooks, E. G., Notarangelo, L. D., Spanopoulou, E., Pan, Z. Q., Vezzoni, P., &amp; others. (2000). Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V (D) J recombination and result in primary immunodeficiencies. <i>Molecular and Cellular Biology</i>, <i>20</i>(15), 5653–5664.</span></li>
<li><span id="gruber2009clinical">Gruber, T. A., Shah, A. J., Hernandez, M., Crooks, G. M., Abdel-Azim, H., Gupta, S., McKnight, S., White, D., Kapoor, N., &amp; Kohn, D. B. (2009). Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency. <i>Pediatric Transplantation</i>, <i>13</i>(2), 244–250.</span></li>
<li><span id="Havrilla220814">Havrilla, J. M., Pedersen, B. S., Layer, R. M., &amp; Quinlan, A. R. (2017). A map of constrained coding regions in the human genome. <i>BioRxiv</i>. https://doi.org/10.1101/220814</span></li>
<li><span id="henderson2013expanding">Henderson, L. A., Frugoni, F., Hopkins, G., de Boer, H., Pai, S.-Y., Lee, Y. N., Walter, J. E., Hazen, M. M., &amp; Notarangelo, L. D. (2013). Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. <i>Journal of Allergy and Clinical Immunology</i>, <i>132</i>(4), 969–971.</span></li>
<li><span id="hiom1998dna">Hiom, K., Melek, M., &amp; Gellert, M. (1998). DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. <i>Cell</i>, <i>94</i>(4), 463–470.</span></li>
<li><span id="Huang:224980">Huang, Z., Ayday, E., Lin, H., Aiyar, R. S., Molyneaux, A., Xu, Z., Fellay, J., Steinmetz, L. M., &amp; Hubaux, J.-P. (2016). A privacy-preserving solution for compressed storage and selective retrieval of genomic data. <i>Genome Research</i>, <i>26</i>(12), 10. 1687–1696.</span></li>
<li><span id="huang2016discovery">Huang, S., Tao, X., Yuan, S., Zhang, Y., Li, P., Beilinson, H. A., Zhang, Y., Yu, W., Pontarotti, P., Escriva, H., &amp; others. (2016). Discovery of an active RAG transposon illuminates the origins of V (D) J recombination. <i>Cell</i>, <i>166</i>(1), 102–114.</span></li>
<li><span id="Humphrey1996vmd">Humphrey, W., Dalke, A., &amp; Schulten, K. (1996). VMD – Visual Molecular Dynamics. <i>Journal of Molecular Graphics</i>, <i>14</i>, 33–38.</span></li>
<li><span id="itan2016mutation">Itan, Y., Shang, L., Boisson, B., Ciancanelli, M. J., Markle, J. G., Martinez-Barricarte, R., Scott, E., Shah, I., Stenson, P. D., Gleeson, J., &amp; others. (2016). The mutation significance cutoff: gene-level thresholds for variant predictions. <i>Nature Methods</i>, <i>13</i>(2), 109.</span></li>
<li><span id="john2016unrelated">John, T., Walter, J. E., Schuetz, C., Chen, K., Abraham, R. S., Bonfim, C., Boyce, T. G., Joshi, A. Y., Kang, E., Carvalho, B. T. C., &amp; others. (2016). Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency. <i>Journal of Clinical Immunology</i>, <i>36</i>(7), 725–732.</span></li>
<li><span id="kapitonov2005rag1">Kapitonov, V. V., &amp; Jurka, J. (2005). RAG1 core and V (D) J recombination signal sequences were derived from Transib transposons. <i>PLoS Biology</i>, <i>3</i>(6), e181.</span></li>
<li><span id="kato2015rag1">Kato, T., Crestani, E., Kamae, C., Honma, K., Yokosuka, T., Ikegawa, T., Nishida, N., Kanegane, H., Wada, T., Yachie, A., &amp; others. (2015). RAG1 deficiency may present clinically as selective IgA deficiency. <i>Journal of Clinical Immunology</i>, <i>35</i>(3), 280–288.</span></li>
<li><span id="kircher2014general">Kircher, M., Witten, D. M., Jain, P., O’roak, B. J., Cooper, G. M., &amp; Shendure, J. (2014). A general framework for estimating the relative pathogenicity of human genetic variants. <i>Nature Genetics</i>, <i>46</i>(3), 310.</span></li>
<li><span id="kido2018minor">Kido, T., Sikora-Wohlfeld, W., Kawashima, M., Kikuchi, S., Kamatani, N., Patwardhan, A., Chen, R., Sirota, M., Kodama, K., Hadley, D., &amp; others. (2018). Are minor alleles more likely to be risk alleles? <i>BMC Medical Genomics</i>, <i>11</i>(1), 3.</span></li>
<li><span id="kwan2014newborn">Kwan, A., Abraham, R. S., Currier, R., Brower, A., Andruszewski, K., Abbott, J. K., Baker, M., Ballow, M., Bartoshesky, L. E., Bonagura, V. R., &amp; others. (2014). Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. <i>Jama</i>, <i>312</i>(7), 729–738.</span></li>
<li><span id="kuijpers2011idiopathic">Kuijpers, T. W., IJspeert, H., van Leeuwen, E. M. M., Jansen, M. H., Hazenberg, M. D., Weijer, K. C., Van Lier, R. A. W., &amp; van der Burg, M. (2011). Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. <i>Blood</i>, blood–2011.</span></li>
<li><span id="kutukculer2012novel">Kutukculer, N., Gulez, N., Karaca, N. E., Aksu, G., &amp; Berdeli, A. (2012). Novel mutatıons and diverse clinical phenotypes in recombınase-activating gene 1 deficiency. <i>Italian Journal of Pediatrics</i>, <i>38</i>(1), 8.</span></li>
<li><span id="kumanovics2017estimated">Kumánovics, A., Lee, Y. N., Close, D. W., Coonrod, E. M., Ujhazi, B., Chen, K., MacArthur, D. G., Krivan, G., Notarangelo, L. D., &amp; Walter, J. E. (2017). Estimated disease incidence of RAG1/2 mutations: A case report and querying the Exome Aggregation Consortium. <i>Journal of Allergy and Clinical Immunology</i>, <i>139</i>(2), 690–692.</span></li>
<li><span id="lawless2018prevalence">Lawless, D., Geier, C. B., Farmer, J. R., Allen, H. L., Thwaites, D., Atschekzei, F., Brown, M., Buchbinder, D., Burns, S. O., Butte, M. J., &amp; others. (2018). Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. <i>Journal of Allergy and Clinical Immunology</i>.</span></li>
<li><span id="lee2014systematic">Lee, Y. N., Frugoni, F., Dobbs, K., Walter, J. E., Giliani, S., Gennery, A. R., Al-Herz, W., Haddad, E., LeDeist, F., Bleesing, J. H., &amp; others. (2014). A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. <i>Journal of Allergy and Clinical Immunology</i>, <i>133</i>(4), 1099–1108.</span></li>
<li><span id="lee2016characterization">Lee, Y. N., Frugoni, F., Dobbs, K., Tirosh, I., Du, L., Ververs, F. A., Ru, H., de Bruin, L. O., Adeli, M., Bleesing, J. H., &amp; others. (2016). Characterization of T and B cell repertoire diversity in patients with RAG deficiency. <i>Science Immunology</i>, <i>1</i>(6).</span></li>
<li><span id="lek2016analysis">Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., Cummings, B. B., &amp; others. (2016). Analysis of protein-coding genetic variation in 60,706 humans. <i>Nature</i>, <i>536</i>(7616), 285.</span></li>
<li><span id="libbrecht2015machine">Libbrecht, M. W., &amp; Noble, W. S. (2015). Machine learning applications in genetics and genomics. <i>Nature Reviews Genetics</i>, <i>16</i>(6), 321.</span></li>
<li><span id="Liggett208066">Liggett, L. A., Sharma, A., De, S., &amp; DeGregori, J. (2017). Conserved patterns of somatic mutations in human peripheral blood cells. <i>BioRxiv</i>. https://doi.org/10.1101/208066</span></li>
<li><span id="mombaerts1992rag">Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., &amp; Papaioannou, V. E. (1992). RAG-1-deficient mice have no mature B and T lymphocytes. <i>Cell</i>, <i>68</i>(5), 869–877.</span></li>
<li><span id="noordzij2002immunophenotypic">Noordzij, J. G., de Bruin-Versteeg, S., Verkaik, N. S., Vossen, J. M. J. J., de Groot, R., Bernatowska, E., Langerak, A. W., van Gent, D. C., &amp; van Dongen, J. J. M. (2002). The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. <i>Blood</i>, <i>100</i>(6), 2145–2152.</span></li>
<li><span id="notarangelo2016human">Notarangelo, L. D., Kim, M.-S., Walter, J. E., &amp; Lee, Y. N. (2016). Human RAG mutations: biochemistry and clinical implications. <i>Nature Reviews Immunology</i>, <i>16</i>(4), 234.</span></li>
<li><span id="oettinger1990rag">Oettinger, M. A., Schatz, D. G., Gorka, C., &amp; Baltimore, D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V (D) J recombination. <i>Science</i>, <i>248</i>(4962), 1517–1523.</span></li>
<li><span id="Organick114553">Organick, L., Ang, S. D., Chen, Y.-J., Lopez, R., Yekhanin, S., Makarychev, K., Racz, M. Z., Kamath, G., Gopalan, P., Nguyen, B., Takahashi, C., Newman, S., Parker, H.-Y., Rashtchian, C., Stewart, K., Gupta, G., Carlson, R., Mulligan, J., Carmean, D., … Strauss, K. (2017). Scaling up DNA data storage and random access retrieval. <i>BioRxiv</i>. https://doi.org/10.1101/114553</span></li>
<li><span id="payne2018cost">Payne, K., Gavan, S. P., Wright, S. J., &amp; Thompson, A. J. (2018). Cost-effectiveness analyses of genetic and genomic diagnostic tests. <i>Nature Reviews Genetics</i>.</span></li>
<li><span id="picard2018international">Picard, C., Gaspar, H. B., Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Crow, Y. J., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., &amp; others. (2018). International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity. <i>Journal of Clinical Immunology</i>, <i>38</i>(1), 96–128.</span></li>
<li><span id="reiff2013exome">Reiff, A., Bassuk, A. G., Church, J. A., Campbell, E., Bing, X., &amp; Ferguson, P. J. (2013). Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease. <i>Journal of Clinical Immunology</i>, <i>33</i>(8), 1289–1292.</span></li>
<li><span id="rieux1998highly">Rieux-Laucat, F., Bahadoran, P., Brousse, N., Selz, F., Fischer, A., Le Deist, F., &amp; De Villartay, J. P. (1998). Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn’s syndrome. <i>The Journal of Clinical Investigation</i>, <i>102</i>(2), 312–321.</span></li>
<li><span id="riccetto2014compound">Riccetto, A. G. L., Buzolin, M., Fernandes, J. F., Traina, F., Barjas-de-Castro, M. L. R., Silva, M. T. N., Oliveira, J. B., &amp; Vilela, M. M. (2014). Compound Heterozygous RAG2 Mutations Mimicking Hyper IgM Syndrome. <i>Journal of Clinical Immunology</i>, <i>34</i>(1), 7–9.</span></li>
<li><span id="ru2015molecular">Ru, H., Chambers, M. G., Fu, T.-M., Tong, A. B., Liao, M., &amp; Wu, H. (2015). Molecular mechanism of V (D) J recombination from synaptic RAG1-RAG2 complex structures. <i>Cell</i>, <i>163</i>(5), 1138–1152.</span></li>
<li><span id="schatz1989v">Schatz, D. G., Oettinger, M. A., &amp; Baltimore, D. (1989). The V (D) J recombination activating gene, Rag-1. <i>Cell</i>, <i>59</i>(6), 1035–1048.</span></li>
<li><span id="schuetz2008immunodeficiency">Schuetz, C., Huck, K., Gudowius, S., Megahed, M., Feyen, O., Hubner, B., Schneider, D. T., Manfras, B., Pannicke, U., Willemze, R., &amp; others. (2008). An immunodeficiency disease with RAG mutations and granulomas. <i>New England Journal of Medicine</i>, <i>358</i>(19), 2030–2038.</span></li>
<li><span id="schwarz1996rag">Schwarz, K., Gauss, G. H., Ludwig, L., Pannicke, U., Li, Z., Lindner, D., Friedrich, W., Seger, R. A., Hansen-Hagge, T. E., Desiderio, S., &amp; others. (1996). RAG mutations in human B cell-negative SCID. <i>Science</i>, <i>274</i>(5284), 97–99.</span></li>
<li><span id="shinkai1992rag">Shinkai, Y., Lam, K.-P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., Alt, F. W., &amp; others. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement. <i>Cell</i>, <i>68</i>(5), 855–867.</span></li>
<li><span id="sobacchi2006rag">Sobacchi, C., Marrella, V., Rucci, F., Vezzoni, P., &amp; Villa, A. (2006). RAG-dependent primary immunodeficiencies. <i>Human Mutation</i>, <i>27</i>(12), 1174–1184.</span></li>
<li><span id="stenson2014human">Stenson, P. D., Mort, M., Ball, E. V., Shaw, K., Phillips, A. D., &amp; Cooper, D. N. (2014). The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. <i>Human Genetics</i>, <i>133</i>(1), 1–9.</span></li>
<li><span id="Stone1998Ane">Stone, J. (1998). <i>An Efficient Library for Parallel Ray Tracing and Animation</i> [Master's thesis]. Computer Science Department, University of Missouri-Rolla.</span></li>
<li><span id="stothard2000sequence">Stothard, P. (2000). The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. <i>University of Alberta, Education and Research Archive</i>.</span></li>
<li><span id="tirosh2018recombination">Tirosh, I., Yamazaki, Y., Frugoni, F., Ververs, F. A., Allenspach, E. J., Zhang, Y., Burns, S., Al-Herz, W., Noroski, L., Walter, J. E., &amp; others. (2018). Recombination activity of human RAG2 mutations and correlation with the clinical phenotype. <i>Journal of Allergy and Clinical Immunology</i>.</span></li>
<li><span id="villa1998partial">Villa, A., Santagata, S., Bozzi, F., Giliani, S., Frattini, A., Imberti, L., Gatta, L. B., Ochs, H. D., Schwarz, K., Notarangelo, L. D., &amp; others. (1998). Partial V (D) J recombination activity leads to Omenn syndrome. <i>Cell</i>, <i>93</i>(5), 885–896.</span></li>
<li><span id="villa2001v">Villa, A., Sobacchi, C., Notarangelo, L. D., Bozzi, F., Abinun, M., Abrahamsen, T. G., Arkwright, P. D., Baniyash, M., Brooks, E. G., Conley, M. E., &amp; others. (2001). V (D) J recombination defects in lymphocytes due toRAG mutations: severe immunodeficiency with a spectrum of clinical presentations. <i>Blood</i>, <i>97</i>(1), 81–88.</span></li>
<li><span id="walter2015broad">Walter, J. E., Rosen, L. B., Csomos, K., Rosenberg, J. M., Mathew, D., Keszei, M., Ujhazi, B., Chen, K., Lee, Y. N., Tirosh, I., &amp; others. (2015). Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. <i>The Journal of Clinical Investigation</i>, <i>125</i>(11), 4135–4148.</span></li>
<li><span id="yu2014human">Yu, X., Almeida, J. R., Darko, S., van der Burg, M., DeRavin, S. S., Malech, H., Gennery, A., Chinn, I., Markert, M. L., Douek, D. C., &amp; others. (2014). Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. <i>Journal of Allergy and Clinical Immunology</i>, <i>133</i>(4), 1109–1115.</span></li>
<li><span id="zhang2005novel">Zhang, J., Quintal, L., Atkinson, A., Williams, B., Grunebaum, E., &amp; Roifman, C. M. (2005). Novel RAG1 mutation in a case of severe combined immunodeficiency. <i>Pediatrics</i>, <i>116</i>(3), e445–e449.</span></li></ol>
:ET